Polish oncological efforts have received much praise in the media recently, yet Poland’s oncology still faces formidable challenges. The head of Maria Skłodowska-Curie Oncology Institute in Warsaw Professor Jan Walewski told PolandIN about the current oncological situation in the country.
“Polish oncology is facing challenges and suffering from some shortages,” said Professor Walewski, adding that the greatest challenge is the epidemiological situation because the mean mortality from cancer in Poland exceeds the European mean.
The frequency of cancer incidents is lower than the mean for European countries. “It is a very inconvenient epidemiological situation and much of the state, ministry and our institute’s efforts are being made to improve this condition… by decreasing incidents [prevalence] and improving… the efficiency of anti-cancer treatment.”
Nevertheless, Poland is considered a vanguard of cancer treatment and prevention, particularly due to its “programme for the detection of colorectal cancer based on colonoscopy,” which is considered an exemplary system for the world. “Many wealthier countries do not possess such an advanced early detection programme,” said Professor Walewski.
To learn what initiatives were recently implemented to reduce the incidents of cancer in Poland, watch the full interview here. Professor Jan Walewski is a specialist in the treatment of internal diseases, clinical oncology, haematology and organ transplants. In addition, he is a holder of the Foreign Medical Graduates Examination in Medical Sciences ECFMG (1992) certificate.
Professor Jan Walewski has contributed to optimising treatment for Burkitt lymphoma and lymphoblastic T-cell lymphoma and the completion of a clinical programme for the transplantation of haemogenic cells. Among other research, he has conducted clinical trials on vaccines extracted from dendritic cells and their injection to indolent lymphoma.